Combinational Gene Therapy toward Cancer with Nanoplatform: Strategies and Principles-Reference-Cited by-同舟云学术

Combinational Gene Therapy toward Cancer with Nanoplatform: Strategies and Principles

Published:2023-07-27 Issue:6 Volume:3 Page:584-599
ISSN:2694-2461
Container-title:ACS Materials Au
language:en
Short-container-title:ACS Mater. Au

Author:

Lin Jinhui¹²,Wang Xinlian¹²,Ni Dongqi¹²,Chen Yandong¹,Chen Chunying¹²^ORCID,Liu Ying¹^ORCID

Affiliation:

1. CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety and CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology of China, Beijing 100190, P.R. China

2. University of Chinese Academy of Sciences, Beijing 100049, P.R. China

Funder

China Postdoctoral Science Foundation

National Natural Science Foundation of China

Publisher

American Chemical Society (ACS)

Subject

Polymers and Plastics,Materials Chemistry,Electronic, Optical and Magnetic Materials,Biomaterials

Link

https://pubs.acs.org/doi/pdf/10.1021/acsmaterialsau.3c00035

Reference123 articles.

1. Cancer statistics, 2022

2. Cancer treatment and survivorship statistics, 2019

3. Cancer cell nucleus-targeting nanocomposites for advanced tumor therapeutics

4. Photothermal therapy and photoacoustic imaging via nanotheranostics in fighting cancer

5. Combinational application of metal–organic frameworks‐based nanozyme and nucleic acid delivery in cancer therapy

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nanostructure-reinforced multifunctional hydrogels for synergistic cancer therapy;Coordination Chemistry Reviews;2025-01

2. Emerging IL-12-based nanomedicine for cancer therapy;Nano Today;2024-08

3. Bioengineered Abiotic Nanomaterials Through Cell Membrane‐Camouflaging: Advancements and Challenges in Lung Cancer;Advanced Healthcare Materials;2024-07-08

4. Synergistic Polymer Blending Informs Efficient Terpolymer Design and Machine Learning Discerns Performance Trends for pDNA Delivery;Bioconjugate Chemistry;2024-06-26

5. The sensitivity of acute myeloid leukemia cells to cytarabine is increased by suppressing the expression of Heme oxygenase-1 and hypoxia-inducible factor 1-alpha;Cancer Cell International;2024-06-25